Current Recommendations for the Treatment of Bronchial Obstructive Diseases: GINA and GOLD Guidelines

Bronchial obstructive diseases, including asthma and chronic obstructive pulmonary disease (COPD), affect millions globally and can significantly impact quality of life, daily functioning, and emotional well-being. These diseases are characterized by airway obstruction, inflammation, and episodes of exacerbations that can range from mild to lifethreatening. The Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) provide updated, evidence-based guidelines for the management of these conditions. This article presents a comprehensive overview of current recommendations for treating asthma and COPD, focusing on acute attack management, long-term pharmacologic therapy, non-pharmacologic interventions, preventive strategies, patient education, and comorbidity management. The content is humanized to reflect patient-centered care and practical clinical application.